Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asembia is a private U.S. healthcare services and technology company focused on specialty pharmacy, patient access, group purchasing, and pharmaceutical channel services. The company supports pharmacies, pharma and biotech manufacturers, prescribers, and patients through a combination of network services, patient support programs, distribution strategy, data and analytics, and workflow software. Asembia helped establish specialty pharmacy as a distinct trade channel and operates the Asembia Specialty Pharmacy Network (ASPN), which connects manufacturers with a broad pharmacy network. Its technology offerings include Asembia-1 and related prescriber, prior authorization, analytics, and manufacturer dashboard tools. The business appears to be a commercial services and infrastructure company rather than a drug developer, with no disclosed therapeutic pipeline of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Assembia.